The Effects of Drugs Used in Anaesthesia on Platelet Membrane Receptors and on Platelet Function

2002 ◽  
Vol 3 (3) ◽  
Author(s):  
Sibylle A. Kozek-Langenecker
Platelets ◽  
2012 ◽  
Vol 24 (5) ◽  
pp. 383-391 ◽  
Author(s):  
Elena Gupalo ◽  
Cynthia Kuk ◽  
Mohammad Qadura ◽  
Liudmila Buriachkovskaia ◽  
Maha Othman

1977 ◽  
Author(s):  
Robert W. Colman

Individuals with familial hyperbetalipoproteinemia are at increased risk of premature atherosclerosis and thrombosis. Although there is controversy whether platelet survival is shortened or normal in this disease, several in vitro tests of platelet function after stimulation with ADP including electrophoretic migration, platelet factor 3, aggregation response and release of nucleotides have been found to be increased. These functional changes are accompanied by an increase of cholesterol to phospholipid ratio in the platelet membrane. Clofibrate and halofenate reverse some of these abnormalities in vitro and the former drug, when administered for 6 weeks to patients with type IIa hyperlipoproteinemia decreases platelet sensitivity to ADP and epinephrine. The platelet hypersensitivity to aggregating agents can be reproduced in vitro by increasing the cholesterol to phospholipid rather in normal platelets. These artificially hypersensitive platelets can be returned to normal by halofenate in vitro. Incorporation of cholesterol into platelet membranes increases the basal level of the membrane associated enzyme adenylate cyclase. However, the enzyme no longer responds to stimulation by prostaglandin E1, and this is associated with relative resistance of the platelet to inhibition by this pharmacologic agent. These functional alterations produced by cholesterol enrichment of platelet membranes occur in parallel with an increase in platelet membrane microviscosity suggesting that the more rigid membrane can alter the behavior cf membrane associated enzymes and receptors.


1999 ◽  
Vol 96 (s40) ◽  
pp. 3P-3P
Author(s):  
G Bashir ◽  
A Bakhai ◽  
HE Gendi ◽  
M Sumiya ◽  
NA Flores ◽  
...  

2016 ◽  
Vol 14 (3) ◽  
pp. 2052-2060 ◽  
Author(s):  
Wen-Jun Liu ◽  
Jing Bai ◽  
Qu-Lian Guo ◽  
Zhe Huang ◽  
Hong Yang ◽  
...  

2021 ◽  
Vol 7 ◽  
Author(s):  
Jiayu Wu ◽  
Johan W. M. Heemskerk ◽  
Constance C. F. M. J. Baaten

The activities of adhesion and signaling receptors in platelets are controlled by several mechanisms. An important way of regulation is provided by proteolytic cleavage of several of these receptors, leading to either a gain or a loss of platelet function. The proteases involved are of different origins and types: (i) present as precursor in plasma, (ii) secreted into the plasma by activated platelets or other blood cells, or (iii) intracellularly activated and cleaving cytosolic receptor domains. We provide a comprehensive overview of the proteases acting on the platelet membrane. We describe how these are activated, which are their target proteins, and how their proteolytic activity modulates platelet functions. The review focuses on coagulation-related proteases, plasmin, matrix metalloproteinases, ADAM(TS) isoforms, cathepsins, caspases, and calpains. We also describe how the proteolytic activities are determined by different platelet populations in a thrombus and conversely how proteolysis contributes to the formation of such populations.


Sign in / Sign up

Export Citation Format

Share Document